You are viewing: France Pharmaceutical Membrane Filtration Market analysis

The France Pharmaceutical Membrane Filtration Market was valued at $328.6 Million in 2024 and projected to reach to $628.3 Million by 2029, representing a compound annual growth rate of 13.8%. France's pharmaceutical membrane filtration market is poised for significant expansion, driven by the country's established position as a European pharmaceutical manufacturing center and increasing biopharmaceutical production.

France Pharmaceutical Membrane Filtration Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

France Pharmaceutical Membrane Filtration Market Trends and Insights

  • This growth trajectory reflects France's strong position as a leading pharmaceutical manufacturing hub in Europe, where stringent regulatory standards and advanced biopharmaceutical production drive demand for high-performance filtration technologies.
  • France's commitment to quality assurance and contamination control in drug manufacturing has positioned membrane filtration as a critical component of the production workflow. The 13.8% compound annual growth rate in France outpaces the global average of 13.1%, underscoring the country's accelerating adoption of membrane filtration solutions.
  • France's pharmaceutical sector, supported by robust R&D investments and a skilled workforce, continues to modernize production facilities with advanced separation and purification technologies.
  • Between 2024 and 2029, France is expected to see increased deployment of ultrafiltration, microfiltration, and nanofiltration systems across sterile injectable manufacturing, vaccine production, and biologics processing. Key drivers include France's expanding biosimilar and monoclonal antibody production capacity, regulatory compliance requirements, and the country's strategic focus on pharmaceutical self-sufficiency and innovation within the European Union..

Key Market Statistics

  • CAGR (2024-2029) 13.8% CAGR
  • Market Size, 2024 ~USD 328.6 Million
  • Forecast, 2029 ~USD 628.3 Million
  • Country France

France Pharmaceutical Membrane Filtration Market Overview

Market Valuation & Growth :

France's pharmaceutical membrane filtration market is valued at USD 328.6 million in 2024, with a robust CAGR of 13.8% projected through 2029, outpacing the global growth rate of 13.1%.

European Manufacturing Leadership :

France maintains a strategic position as a leading pharmaceutical manufacturing hub in Europe, with advanced biopharmaceutical production facilities driving sustained demand for high-performance filtration technologies.

Regulatory Compliance Driver :

Stringent EU and French regulatory standards for pharmaceutical production create consistent demand for advanced membrane filtration solutions that ensure product purity and safety compliance.

Forecast Expansion :

The market is projected to nearly double, reaching USD 628.3 million by 2029, reflecting increasing investments in biopharmaceutical manufacturing and process optimization across French facilities.

France Pharmaceutical Membrane Filtration Market Dynamics

  • The 13.8% CAGR reflects growing investments in advanced filtration technologies to meet stringent EU regulatory requirements and enhance product quality standards.
  • French pharmaceutical companies are increasingly adopting membrane filtration for both small-molecule and biopharmaceutical applications, supporting market growth.
  • The forecast to USD 628.3 million by 2029 underscores strong market fundamentals and sustained demand for high-performance filtration solutions in France's competitive pharmaceutical landscape..

Related Ecosystem

Biotechnology

Top Technologies
  • Reagents
  • Polymerase Chain Reaction (PCR)
  • Stem Cells
  • Assay Kits
  • Flow Cytometers
Top Companies
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.

    Pharmaceuticals

    Top Technologies
    • Bioreactors
    • Analytical Testing
    • Bioanalytical Testing Services
    • Cell Counters
    • Data Management Services
    Top Companies
    • Merck KGaA
    • Thermo Fisher Scientific Inc.
    • SANOFI
    • NOVARTIS
    • Pfizer Inc.

      Key Takeaways

      • France's pharmaceutical membrane filtration market is valued at USD 328.6 million in 2024 and is forecast to grow to USD 628.3 million by 2029, representing a 13.8% CAGR.
      • France's growth rate of 13.8% exceeds the global CAGR of 13.1%, reflecting the country's accelerated modernization of biopharmaceutical manufacturing infrastructure.
      • France's position as a European pharmaceutical leader drives demand for advanced filtration technologies in vaccine, biosimilar, and monoclonal antibody production.
      • Regulatory compliance, contamination control standards, and EU pharmaceutical self-sufficiency initiatives are key growth catalysts for membrane filtration adoption in France.

      Pharmaceutical Membrane Filtration Market Report Scope

      Report Metric Details
      Base Year 2024
      Fastest Growing Segment POLYETHERSULFONE MEMBRANE FILTERS (Type)
      Forecast Period 2024–2029
      Growth Rate CAGR of 13.1% from 2024 to 2029
      Largest Segment MEMBRANE FILTERS (Product)
      Market Size Base Year (Billions) ~USD 10.59 (2024)
      Revenue Forecast (Billions) ~USD 19.6 (2029)
      Segments Covered Product, Type, Technique, Application, Scale Of Operation

      France Pharmaceutical Membrane Filtration Market Report Segmentation

      5 segment dimensions are covered across the global market.

      By Product

      • Membrane Filters
      • Other Products
      • Systems

      By Type

      • Accessories
      • Active Pharmaceutical Ingredient Filtration
      • Bioburden Testing
      • Formulation And Filling Solutions
      • Media And Buffer Filtration
      • Membrane Filtration Assemblies
      • Mixed Cellulose Ester & Cellulose Acetate Membrane Filters
      • Non-Sterile Filtration
      • Nylon Membrane Filters
      • Other Membrane Filters
      • Polycarbonate Track-Etched Membrane Filters
      • Polyethersulfone Membrane Filters
      • Polytetrafluoroethylene Membrane Filters
      • Polyvinylidene Difluoride Membrane Filters
      • Prefiltration
      • Protein Purification
      • Reusable Systems
      • Single-Use Systems
      • Sterile Filtration
      • Vaccine And Antibody Processing
      • Viral Clearance

      By Technique

      • Microfiltration
      • Nanofiltration
      • Other Techniques
      • Ultrafiltration

      By Application

      • Air Purification
      • Cell Separation
      • Final Product Processing
      • Raw Material Filtration
      • Water Purification

      By Scale Of Operation

      • Manufacturing Scale
      • Pilot Scale
      • R&D Scale

      FRANCE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022–2029

      Segment20222023202420252026202720282029CAGR (%)
      AIR PURIFICATION30.932.433.335.23841.947.454.810.5
      CELL SEPARATION54.658.661.866.974.183.997.4115.813.4
      FINAL PRODUCT PROCESSING141.7153.1162.4177.1197.4225262.8314.614.1
      RAW MATERIAL FILTRATION110118.5125.1135.9150.9171.4199.4237.913.7
      WATER PURIFICATION46.75052.556.762.570.681.796.813
      TOTAL383.9412.6435471.8523592.8688.682013.5

      Target Audience

      • French Pharmaceutical Manufacturers : Domestic and multinational pharma companies operating in France need market insights to optimize filtration investments, benchmark against competitors, and align production strategies with market growth trends.
      • Membrane Filtration Equipment Suppliers : Equipment manufacturers and technology providers require France-specific demand forecasts and market segmentation data to develop targeted sales strategies and product offerings for the French pharmaceutical sector.
      • Biopharmaceutical Contract Manufacturers (CMOs) : French and European CMOs need detailed market analysis to justify capital investments in advanced filtration infrastructure and demonstrate value to pharmaceutical clients seeking manufacturing partnerships in France.
      • Investment & Private Equity Firms : Investors evaluating opportunities in France's pharmaceutical sector require comprehensive market data to assess growth potential, identify acquisition targets, and make informed investment decisions in filtration technology companies.
      • Regulatory & Compliance Consultants : Consultants advising pharmaceutical companies on French and EU compliance need market-specific insights to guide clients on filtration technology adoption and regulatory alignment strategies.

      Key Companies in the France Pharmaceutical Membrane Filtration Market

      CompanyHQOwnershipStrongest segments
      VALMET CORPORATIONFinlandPublic CompanyBiomaterial Solutions and Services (pulp, paper, tissue, packaging lines and lifecycle services),Process Performance Solutions – Automation systems and industrial applications,Process Performance Solutions – Flow control (valves, pumps, valve automation),
      MERCK KGAAUnited StatesPublic CompanyLife Science (reagents, consumables, devices, instruments, software, services, bioprocessing solutions, CDMO/testing),Healthcare (prescription drugs and biopharmaceuticals across oncology, rare diseases, neurology and immunology, fertility, cardiovascular, metabolic and endocrinological disorders),Electronics (semiconductor materials, specialty gases, delivery equipment, display and photonics materials),
      DANAHER CORPORATIONUnited StatesPublic CompanyBiotechnology (Bioprocessing and Single-Use Solutions),Life Sciences (Instruments and Consumables),Diagnostics (Clinical Instruments and Consumables),
      SARTORIUS AGUnited StatesPublic CompanyBioprocess solutions (bioreactors, cell culture, process filtration & chromatography, fluid management),Lab products & services (lab filtration, weighing, pipettes, microbiological testing, lab water, OEM),Analytical & cell analysis solutions (BLI, cytometry screening, PAT & data analytics, live-cell imaging, SPR, cell selection),
      THERMO FISHER SCIENTIFIC INC.United StatesPublic CompanyLife Sciences Solutions (reagents, instruments, consumables),Analytical Instruments,Specialty Diagnostics,
      3M COMPANYUnited StatesPublic CompanySafety and Industrial,Transportation and Electronics,Consumer,
      PARKER HANNIFIN CORPORATIONUnited StatesPublic CompanyIndustrial motion and control (hydraulics, pneumatics, electromechanical),Sealing, adhesives, and thermal management,Filtration and fluid management,
      REPLIGEN CORPORATIONUnited StatesPublic CompanyFiltration and cell retention (XCell ATF, TangenX, KrosFlo, TFDF, ProConnex),Chromatography systems, columns, and resins (OPUS, KRM, resins, AVIPure),Process analytics and PAT (PATsmart MAVERICK/MAVEN/REBEL/ZipChip, SoloVPE/FlowVPE),
      ASAHI KASEI CORPORATIONJapanPublic CompanyAdvanced materials for semiconductors and electronics,Battery separators and energy-related materials,Membranes and process systems,
      EATON CORPORATION PLCIrelandPublic CompanyElectrical Americas,Electrical Global,Aerospace,
      GEA GROUPGermanyPublic CompanySeparation & Flow Technologies (separators, decanters, valves, pumps, homogenizers),Liquid & Power Technologies (brewing, liquid processing, filling, concentration, fermentation),Food & Health Technologies (meat, poultry, seafood, vegan processing; slicing; pharma equipment),
      CORNING INCORPORATEDUnited StatesPublic CompanyOptical communications (fiber, cable, hardware, components),Display glass substrates (LCD and OLED),Specialty materials (mobile, semiconductor optics, sunglasses, shielding),
      DONALDSON COMPANY, INC.United StatesPublic CompanyMobile Solutions,Industrial Solutions,Life Sciences,
      SAINT-GOBAINFrancePublic CompanyPlasterboard and interior systems (Placo, Rigips, Gyproc, ceilings brands),Insulation solutions (Isover, CertainTeed, Izocam),Mortars and construction chemicals (Weber, Chryso, GCP),

      VALMET CORPORATION

      Valmet Corporation is a Finnish public company founded in 1750 with 18,370 employees. The company has a long-established history in industrial manufacturing and services.

      MERCK KGAA

      Merck KGaA is a United States-based public company with roots dating to 1668 and 59,077 employees. The company operates as a diversified pharmaceutical and chemical enterprise.

      DANAHER CORPORATION

      Danaher Corporation is a United States-based public company founded in 1969 with 59,000 employees. The company operates across multiple industrial and life sciences sectors.

      SARTORIUS AG

      Sartorius AG is a United States-based public company founded in 1870 with 14,242 employees. The company specializes in laboratory and pharmaceutical equipment.

      THERMO FISHER SCIENTIFIC INC.

      Thermo Fisher Scientific Inc. is a United States-based public company founded in 1956 with 125,000 employees. The company is a leading provider of life sciences and analytical instruments.

      3M COMPANY

      3M Company is a United States-based public company founded in 1902 with 60,500 employees. The company manufactures a diverse portfolio of products across multiple industries.

      PARKER HANNIFIN CORPORATION

      Parker Hannifin Corporation is a United States-based public company founded in 1917 with 57,950 employees. The company specializes in motion and control technologies.

      REPLIGEN CORPORATION

      Repligen Corporation is a United States-based public company founded in 1981 with 2,000 employees. The company provides bioprocessing solutions for the life sciences industry.

      ASAHI KASEI CORPORATION

      Asahi Kasei Corporation is a Japanese public company founded in 1922 with 47,895 employees. The company operates across chemicals, materials, and healthcare sectors.

      EATON CORPORATION PLC

      Eaton Corporation PLC is an Ireland-based public company founded in 1911 with 97,303 employees. The company provides diversified industrial power management solutions.

      GEA GROUP

      GEA Group is a German public company founded in 1881 with 19,670 employees. The company specializes in process technology and equipment for various industries.

      CORNING INCORPORATED

      Corning Incorporated is a United States-based public company founded in 1851 with 67,200 employees. The company manufactures specialty glass, ceramics, and related materials.

      DONALDSON COMPANY, INC.

      Donaldson Company, Inc. is a United States-based public company founded in 1915 with 15,000 employees. The company manufactures filtration systems and related products.

      SAINT-GOBAIN

      Saint-Gobain is a French public company founded in 1665 with 158,616 employees. The company is a global leader in building materials and high-performance materials.

      Reasons to Buy this Report

      • France-Specific Market Sizing : Obtain precise market valuation data for France (USD 328.6M in 2024) with country-specific forecasts through 2029, enabling accurate budget allocation and investment planning for French pharmaceutical operations.
      • Competitive Landscape Intelligence : Understand the competitive dynamics specific to France's pharmaceutical membrane filtration sector, including local manufacturers, market consolidation trends, and competitive positioning strategies.
      • Regulatory & Compliance Insights : Gain detailed knowledge of French and EU regulatory requirements driving membrane filtration adoption, helping manufacturers align products with stringent compliance standards in the French market.
      • Growth Opportunity Identification : Identify high-growth segments and application areas within France's pharmaceutical sector where membrane filtration demand is accelerating, supporting strategic expansion and product development decisions.
      • Investment & Partnership Strategy : Leverage France-specific market data to evaluate partnership opportunities, acquisition targets, and investment potential within the country's robust biopharmaceutical manufacturing ecosystem.

      Frequently asked questions

      What is the current market size of pharmaceutical membrane filtration in France?

      France's pharmaceutical membrane filtration market was valued at USD 328.6 million in 2024 and is projected to reach USD 628.3 million by 2029.

      What is the expected growth rate for France's pharmaceutical membrane filtration market?

      France's pharmaceutical membrane filtration market is expected to grow at a compound annual growth rate (CAGR) of 13.8% from 2024 to 2029.

      Why is France's membrane filtration market growing faster than the global average?

      France's 13.8% CAGR exceeds the global 13.1% due to the country's strong pharmaceutical manufacturing base, regulatory requirements, biopharmaceutical expansion, and EU-driven pharmaceutical self-sufficiency initiatives.

      What applications drive membrane filtration demand in France's pharmaceutical sector?

      Key applications in France include sterile injectable manufacturing, vaccine production, biosimilar development, monoclonal antibody processing, and biologics purification.

      Which membrane filtration technologies are most relevant to France's market?

      Ultrafiltration, microfiltration, and nanofiltration systems are the primary technologies deployed across France's pharmaceutical manufacturing facilities for separation and purification processes.

      RESEARCH METHODOLOGY

      This research study involved the extensive use of secondary sources, directories, and databases to identify and collect valuable information for the analysis of the global pharmaceutical membrane filtration market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess the growth prospects of the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.

      Secondary Research:

      Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the pharmaceutical membrane filtration market. The secondary sources used for this study include American Membrane Technology Associations (AMTA), European Membrane Society (EMS),  American Association of Pharmaceutical Scientists (AAPS), Pharmaceutical Research and Manufacturers of America (PhRMA), National Center for Biotechnology Information (NCBI), Parenteral Drug Association (PDA), Food and Drug Administration (FDA), European Medicines Agency (EMA), Health Canada, National Institutes of Health (NIH), World Health Organisation (WHO), Indian Pharmaceutical Association (IPA), International Society for Pharmaceutical Engineering (ISPE), BioProcess International Magazine, BioPharm International, Journal of Bioprocessing and Biotechniques, BioPlan Associates, ScienceDirect, research journals; corporate filings such as annual reports, SEC filings, investor presentations, and financial statements; press releases; trade, business, professional associations and among others. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

      Primary Research:

      Extensive primary research was conducted after acquiring basic knowledge about the global pharmaceutical membrane filtration market scenario through secondary research. Several primary interviews were conducted with market experts from the demand side, such as pharmaceutical and biopharmaceutical companies, CROs, CMOs, and academic & research institutes, and experts from the supply side, such as C-level and D-level executives, product managers, marketing & sales managers of key manufacturers, distributors, and channel partners. These interviews were conducted across six major regions, including the Asia Pacific, North America, Europe, Latin America, Middle East and Africa. Approximately 70% and 30% of the primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

      The following is a breakdown of the primary respondents:

      Pharmaceutical Membrane Filtration Market Size, and Share

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation:

      Both top-down and bottom-up approaches were used to estimate and validate the total size of the pharmaceutical membrane filtration market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

      Bottom-up Approach:

      • The key players in the industry and market have been identified through extensive secondary research
      • The revenues generated from the pharmaceutical membrane filtration business of leading players have been determined through primary and secondary research
      • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

      Pharmaceutical Membrane Filtration Market Size, and Share

      To know about the assumptions considered for the study, Request for Free Sample Report

      Top-down Approach:

      After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments.

      Pharmaceutical Membrane Filtration Market Size, and Share

      Data Triangulation:

      After arriving at the market size  from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

      Market Definition:

      Membrane filtration is a process wherein solid particles present in a suspension are separated from a liquid or gas by employing membrane filters such as filter sheets, filter cartridges, or filter papers. These membrane filters are used to retain solids, thus allowing liquids to pass through. Membrane filters are used in pharmaceutical and biopharmaceutical manufacturing processes.

      Stakeholders:

      • Filter Manufacturers, Vendors, and Distributors
      • Academic and Government Research Institutes
      • Pharmaceutical and Biotechnology Companies
      • Life Science Companies
      • Venture Capitalists and Investors
      • Government Organizations
      • Private Research Firms
      • Contract Research Organizations (CROs)
      • Contract Development and Manufacturing Organizations (CDMOs)

      Report Objectives:

      • To define, describe, and forecast the global pharmaceutical membrane filtration market based on the product, technique, type, application, scale of operation and region
      • To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, opportunities and challenges)
      • To strategically analyze micro-markets with respect to individual growth trends, future prospects, and contributions to the overall pharmaceutical membrane filtration market
      • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
      • To forecast the size of the market segments with respect to six main regions, namely, North America, Europe, Asia Pacific, Latin America, Middle East and Africa
      • To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
      • To track and analyze competitive developments such as acquisitions, product launches, expansions, and R&D activities in the pharmaceutical membrane filtration market.

      Available Customizations:

      With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:

      Portfolio Assessment:

      • Product Matrix, which gives a detailed comparison of the product portfolios of the top three companies.

      Company Information:

      • Detailed analysis and profiling of additional market players (up to three).

      Geographical Analysis:

      • A further breakdown of the Rest of Asia Pacific pharmaceutical membrane filtration market into countries
      • A further breakdown of the Rest of European pharmaceutical membrane filtration market into countries
      • A further breakdown of the Rest of Latin American pharmaceutical membrane filtration market into countries
      • A further breakdown of the Rest of Middle East pharmaceutical membrane filtration market into countries

      Get the Full Pharmaceutical Membrane Filtration Market Report

      Full forecast, segment splits, and company analysis for all Pharmaceutical Membrane Filtration Market.

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      DMCA.com Protection Status